Stockscreener 앱 받기
1.05
4.55%
-0.05
시간 외 거래:
1.07
0.02
+1.90%
전일 마감가:
$1.10
열려 있는:
$1.1
하루 거래량:
64,353
Relative Volume:
0.47
시가총액:
$32.94M
수익:
$90,000
순이익/손실:
$-23.47M
주가수익비율:
-1.3959
EPS:
-0.7522
순현금흐름:
$-22.98M
1주 성능:
+0.00%
1개월 성능:
+22.09%
6개월 성능:
-1.87%
1년 성능:
-39.66%
1일 변동 폭
$1.04
$1.10
1주일 범위
$1.03
$1.15
52주 변동 폭
$0.7351
$1.8059
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
명칭
Actinium Pharmaceuticals Inc
전화
646-767-3870
주소
275 Madison Avenue, 7th Floor, New York, NY
Compare ATNM vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.05 | 35.14M | 90,000 | -23.47M | -22.98M | -0.7522 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-07 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-02-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-25 | 개시 | B. Riley Securities | Buy |
| 2020-11-05 | 개시 | Alliance Global Partners | Buy |
| 2017-12-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | 재개 | ROTH Capital | Buy |
| 2017-09-14 | 개시 | Maxim Group | Buy |
| 2016-08-25 | 개시 | ROTH Capital | Buy |
| 2016-02-29 | 개시 | H.C. Wainwright | Buy |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2014-10-01 | 개시 | MLV & Co | Buy |
| 2014-07-22 | 개시 | Canaccord Genuity | Buy |
모두보기
Actinium Pharmaceuticals Inc 주식(ATNM)의 최신 뉴스
Actinium (ATNM) Chart: Ends Up by 3.24% at $1.11 in Latest Trading; Level Watch: the Supplied Trading Band Runs From $1.05 to $1.17Up Down Ratio - vinanet.vn
KPTI Stock Price and Chart — NASDAQ:KPTI - TradingView
ETFs Investing in Actinium Pharmaceuticals, Inc. Stocks - TradingView
Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS) - The Globe and Mail
Form 8K Actinium Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Nigeria
Actinium Pharmaceuticals Announces Actimab-A Intellectual Property And Manufacturing Advances And Provides NYSE American Listing Update - TradingView
Actinium Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update - PR Newswire
Actinium Pharmaceuticals (ATNM) Institutional Ownership 2026 - MarketBeat
Actinium Pharmaceuticals (ATNM) Slips 3.4% to $0.77 as Key Support at $0.73 Comes into FocusRelative Volume - vinanet.vn
Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. (ATNM) InvestorsLead Plaintiff Deadline on May 27, 2025 - The National Law Review
Actinium Pharmaceuticals, Inc. (Delaware) Revenue Breakdown – AMEX:ATNM - TradingView
Actinium Pharmaceuticals (ATNM) Edges Higher as Stock Holds Above Key SupportSector ETF Flow - dars.gov.et
Class Action Lawsuit Filed: Actinium Pharmaceuticals, Inc. (ATNM)Join by May 27, 2025Contact Levi & Korsinsky - The National Law Review
Actinium Pharmaceuticals Inc (ATNM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Did You Lose Money on Actinium Pharmaceuticals, Inc. (ATNM)? Levi - The National Law Review
ATNM|Actinium Pharmaceuticals Inc|Price:0.860|Chg%:-0.024 - TradingKey
TradingKey - TradingKey
Actinium Pharmaceuticals Inc (ATNM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Actinium Pharmaceuticals (ATNM) Q3 2025 earnings summary - Quartr
Actinium Pharmaceuticals (ATNM) Life Sciences Investor Forum Summary - Quartr
Actinium Pharmaceuticals (ATNM) Dips 2.9% as Biotech Stock Nears Support ZoneVWAP Breakout - dars.gov.et
Actinium Pharmaceuticals (ATNM) Gains 2.77% as Stock Tests Key Resistance Near $0.97Volume Rate Change - vinanet.vn
Actinium Pharmaceuticals (ATNM) Investor presentation Summary - Quartr
Actinium Pharmaceuticals (ATNM) Proxy Filing Summary - Quartr
ATNM Should I Buy - Intellectia AI
Actinium Pharmaceuticals (ATNM) Q4 2025 earnings summary - Quartr
Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Receptor Inhibitors and Offers Flexible, Well-Tolerated Dosing in Prostate Cancer Models - AOL.com
Actinium Company Profile & Introduction - Moomoo
ATNMActinium Pharmaceuticals Inc Earnings - Finviz
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - The National Law Review
Actinium Pharmaceuticals (ATNM) Stages Recovery Attempt Near Critical Support LevelDip Buy Trade - dars.gov.et
ATNM Stockholders Have Opportunity to Lead Actinium Pharmaceutica - The National Law Review
ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceut - The National Law Review
Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Joi - The National Law Review
ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Levi & Korsinsky Notifies Shareholders of Actinium Pharmaceutical - The National Law Review
Enterprise value to revenue forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView
Price to sales forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView
Price to earnings forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView
Price to book forward of Actinium Pharmaceuticals, Inc. (Delaware) – AMEX:ATNM - TradingView
Actinium Pharmaceuticals, Inc. Actuals & Estimates (AMEX:ATNM) - TradingView
ATNM Forecast — Price Target — Prediction for 2027 - TradingView
Actinium Pharmaceuticals Inc (ATNM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Actinium Pharmaceuticals (ATNM) Q1 2026 Earnings: Narrowed Loss Surpasses Expectations Amid Pipeline ProgressTangible Book Value - dars.gov.et
Actinium Submits NYSE Compliance Plan to Restore Listing - The Globe and Mail
Actinium Pharmaceuticals Inc (ATNM) Institutional Confidence - TradingKey
Actinium Pharmaceuticals Inc (ATNM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Actinium Pharmaceuticals Inc (ATNM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Actinium Pharmaceuticals Inc (ATNM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Actinium Pharmaceuticals Submits NYSE American Compliance Plan After Equity Deficiency Notice - Minichart
Actinium Pharmaceuticals Inc (ATNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
3.22%
자본화:
|
볼륨(24시간):